About OceansBIo
OceansBIo is a company based in Changwon (South Korea) founded in 2021. OceansBIo offers products and services including TaVNS. OceansBIo operates in a competitive market with competitors including NeuroPace, Cadence Neuroscience, Engage Therapeutics, NightWatch and Cyberonics, among others.
- Headquarter Changwon, South Korea
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Oceansbio Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OceansBIo
OceansBIo is a publicly listed company on the KRX with ticker symbol 332190 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OceansBIo
OceansBIo offers a comprehensive portfolio of products and services, including TaVNS.
Device that delivers impulses to vagus nerve for neurological relief.
Funding Insights of OceansBIo
Investments & Acquisitions by OceansBIo
Financial Statements - OceansBIo
Oceansbio Comparisons
Competitors of OceansBIo
OceansBIo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroPace, Cadence Neuroscience, Engage Therapeutics, NightWatch and Cyberonics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable neurostimulation systems for epilepsy treatment are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for treating neurological disorders like epilepsy are developed.
|
|
| domain | founded_year | HQ Location |
Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures
|
|
| domain | founded_year | HQ Location |
Wearable armbands for detecting epileptic seizures during sleep are offered.
|
|
| domain | founded_year | HQ Location |
Vagus nerve stimulation therapy is developed for epilepsy and depression.
|
|
| domain | founded_year | HQ Location |
Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders.
|
Latest news on Oceansbio
Frequently Asked Questions about OceansBIo
OceansBIo was founded in 2021.
OceansBIo is headquartered in Changwon, South Korea. It is registered at Changwon, Gyeongsangnam-do, South Korea.
Founded in 2021 and based in Changwon, South Korea, electroceutical devices for epilepsy treatment are developed by the company. Implantable human devices are created using AI technology within the medical device sector. Operations focus on advancing therapeutic solutions for neurological conditions, with emphasis on precise, AI-driven interventions tailored to epilepsy management.
OceansBIo's top competitors include NeuroPace, Engage Therapeutics and Cyberonics.
OceansBIo offers TaVNS.
Yes, OceansBIo is publicly traded on KRX under the ticker symbol 332190.
The ticker symbol of OceansBIo is 332190 on KRX.